Medtronic revenue and financials
$87.09Change from previous close: −1.00%Absolute change: −$0.88
In the fiscal year ended April 2026, Medtronic reported revenue of $36.36B (+8.43% year over year). Net income was $4.8B, a net margin of 13.2%.
Fiscal year ending in April. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +8.43%
- FY to Apr 2026 vs FY to Apr 2025
- Net income growth
- +2.98%
- FY to Apr 2026 vs FY to Apr 2025
- Net margin
- 13.2%
- FY to Apr 2025: 13.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Apr 2026 | FY to Apr 2025 | FY to Apr 2024 | FY to Apr 2023 | FY to Apr 2022 | FY to Apr 2021 | FY to Apr 2020 | FY to Apr 2019 | FY to Apr 2018 | FY to Apr 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 7,330 | 7,044 | 6,787 | 6,039 | 7,346 | 6,240 | 7,234 | 7,007 | 4,684 | 6,880 |
| Depreciation and amortization | 2,958 | 2,861 | 2,647 | 2,697 | 2,707 | 2,702 | 2,663 | 2,659 | 2,644 | 2,917 |
| Capital expenditure | -1,904 | -1,859 | -1,587 | -1,459 | -1,368 | -1,355 | -1,213 | -1,134 | -1,068 | -1,254 |
| Investing cash flow | -2,934 | -1,937 | -2,366 | -3,493 | -1,659 | — | — | — | — | — |
| Financing cash flow | -4,751 | -4,361 | -4,450 | -4,960 | -5,336 | — | — | — | — | — |
| Dividends paid | -3,639 | -3,589 | -3,666 | -3,616 | -3,383 | -3,120 | -2,894 | -2,693 | -2,494 | -2,376 |
| Share repurchases | -1,035 | -3,235 | -2,138 | -645 | -2,544 | -652 | -1,326 | -2,877 | -2,171 | -3,544 |
| Debt issued | 1,756 | 3,209 | 1,073 | 7,693 | — | — | — | — | — | — |
| Debt repaid | -2,930 | -1,070 | — | -8,291 | -1.0 | — | — | — | — | — |
| Effect of exchange rates | 85.0 | 188 | -230 | 243 | -231 | — | — | — | — | — |
| Net change in cash | -269 | 934 | -259 | -2,171 | 121 | — | — | — | — | — |
| Free cash flow | 5,426 | 5,185 | 5,200 | 4,580 | 5,978 | — | — | — | — | — |
| Levered free cash flow | 4,625 | 4,163 | 5,721 | 10,059 | -1,164 | — | — | — | — | — |